Stents / DES – Cre8™

Polymer-free Amphilimus™ (Sirolimus + Fatty Acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption.


Abluminal Reservoir Technology

Controlled and directed drug elution as a result of the Abluminal Reservoir Technology

Amphilimus™ Formulation

Optimal efficacy achieved through an homogeneous drug distribution and improved bioavailability due to the proprietary Amphilimus™ formulation, which is the combination of Sirolimus plus Fatty Acid

Bio Inducer Surface

Proven bio and haemo-compatibility enabled by the Bio Inducer Surface coating, which accelerates the rate of endothelization and reduces thrombogenicity

Product Brochure
Order Information
Technical Information

The images shown within this pages are of a purely illustrative nature and not intended to depict reality. Manufactured by CID S.p.A member of Alvimedica Group.